What are good reasons for in- or outward licensing
a pharmaceutical compound?

“If you don't know where you are going, you will wind up somewhere else" is a quotation (from Yogi Berra) often used in planning and strategy sessions. As for all critical business processes, this applies just as much to pharma & biotech licensing - if you don’t know where you are going at the start of an outward or inward licensing process, the only certainty is that you will not get there.

Licensing plays a crucial role in optimizing company performance. The means by which companies can benefit from inward and outward licensing are summarized here by David Scott, C.E.L.forpharma’s expert-trainer for The Pharmaceutical Out-licensing Course:

“ C.E.L.forpharma's pharmaceutical out-licensing course provided a thorough overview of all steps in the out-licensing process. It helped me to structure my practical experience and enriched my knowledge with international practices in out-licensing activities. For the newcomers this course with David Scott is a very useful and unique source of theoretical information, real life examples and problem-solving solutions. The exchange of participant experiences during coffee breaks is invaluable too.”

Elena Govorova, Business Development Manager, Novartis - Russia